In estrogen receptor (−) breast cancer patients, larger body size was additionally associated with downregulation in genes involved in interferon α and interferon γ immune response and phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin signaling15. The gene discussed is ESR1; the disease is breast carcinoma.